Tag: life sciences
-
Chip Device Finds, Collects Circulating Tumor Cells
A multi-disciplinary team designed a lab-on-a-chip device using hydrodynamic forces to find and help identify circulating tumor cells in blood samples.
-
Gene Therapy Shown to Prevent, Reverse Multiple Sclerosis
Medical researchers show that transferring healthy genes can protect nerve cells in lab mice against damage from multiple sclerosis, and help reverse effects of the disease.
-
Patent Awarded for Live Bacterial Acne Treatment
A company developing treatments for disease by restoring the natural balance of bacteria on the skin received a patent for its acne therapy using spray-on live bacteria.
-
Guidelines Designed for CAR T-Cell Cancer Therapies
Cancer specialists and scientists at several cancer care centers propose safety guidelines for patients receiving engineered immune cell treatments that often have severe adverse effects.
-
Neuro Disease Start-Up Gains $30M in Early Funds
A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round.
-
Microfluidics, Sound Waves Combined for Liquid Biopsies
Biomedical engineers from several universities developed a microfluidics, or lab-on-a-chip, device that uses sound waves to quickly isolate tiny packets of cell materials for detecting diseases.
-
Avian Flu Vaccine with Longer Protection in Development
A biotechnology company is designing a vaccine to protect against the newly emergent avian flu to provide more sustained protection like seasonal flu vaccines.
-
Stem Cells Shown to Heal Chronic Leg Wounds
Experimental treatments using patients’ own stem cells were shown in a pilot test to heal painful chronic wounds on their legs and feet.
-
3-D Organ Printing Company Gains Seed Funds
A start-up enterprise seeking to create replacement human tissue and organs with three-dimensional printing is raising $1.8 million in seed capital.
-
Drug Delivery Technology Licensed in $2B Deals
The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers.